2016 CRO Industry Leaders

2016 Annual CRO Report

Nice Insight’s Top Companies lists are comprised of the highest scoring companies, as rated by buyers of outsourced services, with respect to customer perception within each category.

Customer perception describes how a current buyer or prospect rates a company based on the information they have been exposed to — from marketing materials to word-of-mouth influence, as well as experience with the company. Nice Insight uses six key drivers of outsourcing — quality, reliability, productivity, affordability, innovation and regulatory history — to measure customer perception; the number listed is the average of the six individual scores, down to the decimal point.

PreClinical

General Toxicology

1. Worldwide Clinical Trials  87.33% CP Score Mean 
2. ICON  86.33%
3. MPI Research  85.83%
4. BRI Biopharmaceutical Research  85.67%
5. PPD  85.50%
6. MedPace Inc.  85.33%
7. Toxikon Corporation  85.00%
8. Lambda Therapeutic Research  84.83%
9. American Preclinical Services  84.33%
9. JRF Global  84.33%
9. PRA Health Sciences  84.33%


 

PreClinical

DMPK

1. Evotec  90.50% CP Score Mean
2. Worldwide Clinical Trials  88.67%
3. MPI Research  87.33%
4. CiToxLAB  87.00%
4. ICON  87.00%
6. Seventh Wave Laboratories  86.50%
7. Parexel  86.33%
8. JRF Global  85.83%
9. PRA Health Sciences  85.50%
10. Battelle  85.33%


 

PreClinical

Analytical Testing

1. Blue Sky BioServices  88.00% CP Score Mean
2. Quest Diagnostics Clinical Trials  87.33%
3. Seventh Wave Laboratories  86.50%
4. Parexel  86.33%
5. Evotec  85.67%
5. MicroConstants  85.67%
7. ICON  85.50%
7. MPI Research  85.50%
7. Surpass  85.50%
7. PRA Health Sciences  85.50%


 

PreClinical

Bio-analytical Testing

1. Blue Sky BioServices  87.33% CP Score Mean
2. Novotech  87.00%
3. Quest Diagnostics Clinical Trials  86.83%
4. ICON  86.00%
4. Toxikon Corporation  86.00%
6. Evotec  85.83%
6. Smithers Avanza  85.83%
8. PRA Health Sciences  85.67%
8. CNS Network  85.67%
10. Surpass  85.50%


 

PreClinical

Method Development & Validation

1. BASi  88.33% CP Score Mean
2. Blue Sky BioServices  87.67%
2. Worldwide Clinical Trials  87.67%
4. InnoPharma S.r.l.  87.50%
5. Parexel  87.00%
6. Evotec  86.83%
6. ICON  86.83%
8. PRA Health Sciences  86.67%
9. Quest Diagnostics Clinical Trials  86.33%
10. CiToxLAB  85.83%
10. Product Safety Labs  85.83%


 

Clinical

Clinical Data Management

1. Quest Diagnostics Clinical Trials  88.33% CP Score Mean
2. Novum Pharmaceutical Research Sciences  87.67%
3. InnoPharma S.r.l.  87.33%
4. CNS Network  87.17%
5. InVentiv Health  87.00%
6. ICON  86.50%
7. Parexel  85.83%
7. Worldwide Clinical Trials  85.83%
9. Novotech  85.50%
10. BioSkin GmbH  85.00%
10. Janix  85.00%


 

Clinical

Clinical Trial Recruiting

1. CNS Network  87.50% CP Score Mean
2. InnoPharma S.r.l.  87.17%
2. Janix  87.17%
4. Chiltern  86.83%
5. INC Research  86.17%
5. PRA Health Sciences  86.17%
5. Spaulding Clinical  86.17%
8. Novum Pharmaceutical Research Sciences  85.83%
9. MedPace Inc.  85.67%
10. Envigo  85.33%


 

Clinical

Clinical Trial Design

1. InnoPharma S.r.l.  87.17% CP Score Mean
2. Worldwide Clinical Trials  86.67%
3. InVentiv Health  86.50%
4. Intertek  86.00%
5. PRA Health Sciences  85.67%
6. Parexel  85.50%
7. Novotech  85.33%
8. MedSource  85.17%
9. MedPace Inc.  84.83%
10. CNS Network  84.50%
10. ICON  84.50%


 

Clinical

Clinical Trial Monitoring

1. Parexel  88.67% CP Score Mean
2. InnoPharma S.r.l.  87.83%
3. Piramal Pharma Solutions  87.33%
4. Novum Pharmaceutical Research Sciences  87.17%
4. PRA Health Sciences  87.17%
6. MPI Research  86.83%
6. Novotech  86.83%
6. Premier Research  86.83%
6. Worldwide Clinical Trials  86.83%
10. BRI Biopharmaceutical Research  86.50%


 

Clinical

Project Management

1. Worldwide Clinical Trials  89.67% CP Score Mean
2. Piramal Pharma Solutions  88.00%
3. InnoPharma S.r.l.  86.50%
3. Blue Sky BioServices  86.50%
3. Janix  86.50%
6. SanaClis  86.33%
7. Quest Diagnostics Clinical Trials  86.17%
8. Spaulding Clinical  86.00%
9. MPI Research  85.67%
10. Rho  85.50%

 16Q1_NI_CRO_Survey.jpg

 

Guy Tiene

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.

Q: